Xeris Pharmaceuticals Inc Free Cash Flow Generation Index

Latest as of June 2026: 0.97x

Xeris Pharmaceuticals Inc free cash flow generation index. Xeris Pharmaceuticals Inc (XERS) has a Free Cash Flow Generation Index of 0.97x as of June 2026. Free cash flow of $8.05 Million represents 1% of operating cash flow ($8.26 Million).

FCF Generation Index

0.97x
Free Cash Flow / Operating CF

Free Cash Flow

$8.05 Million
USD

Operating Cash Flow

$8.26 Million
USD

Capital Expenditures

$209.00K
USD

Free Cash Flow Generation Index of Xeris Pharmaceuticals Inc (2025–2025)

Free cash flow generation index of Xeris Pharmaceuticals Inc from 2025 to 2025. Historical FCF Generation Index trend for Xeris Pharmaceuticals Inc across 1 annual periods. See Xeris Pharmaceuticals Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Xeris Pharmaceuticals Inc Free Cash Flow Generation Index by Year (2025–2025)

Xeris Pharmaceuticals Inc free cash flow generation index by year from 2025 to 2025. Year-by-year Free Cash Flow Generation Index for Xeris Pharmaceuticals Inc. For the full cash flow conversion analysis, see Xeris Pharmaceuticals Inc operating cash flow efficiency.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2025 0.98x $27.93 Million $28.63 Million $696.00K —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).